Lirucitinib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C16H25N5OS
Molecular Weight	335.468
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC[S@@](=N)(=O)C[C@H]1CC[C@@H](CC1)N(C)C2=NC=NC3=C2C=CN3

InChI

InChIKey=CPIJQOJWCQTORE-NSCUQIJASA-N

InChI=1S/C16H25N5OS/c1-3-23(17,22)10-12-4-6-13(7-5-12)21(2)16-14-8-9-18-15(14)19-11-20-16/h8-9,11-13,17H,3-7,10H2,1-2H3,(H,18,19,20)/t12-,13-,23-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C16H25N5OS
Molecular Weight	335.468
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 20:35:50 GMT 2025` Edited by `admin` on `Wed Apr 02 20:35:50 GMT 2025`
Record UNII	TD3XJ8R5ZS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Lirucitinib

Official Name

English

(R)-ethyl(imino)({trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methyl)-?<sup>6</sup>-sulfanone

Preferred Name

English

lirucitinib [INN]

Common Name

English

7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-[trans-4-[[[S(R)]-S-ethylsulfonimidoyl]methyl]cyclohexyl]-N-methyl-

Systematic Name

English

Code System Code Type Description

FDA UNII

TD3XJ8R5ZS

Created by admin on Wed Apr 02 20:35:50 GMT 2025 , Edited by admin on Wed Apr 02 20:35:50 GMT 2025

PRIMARY

CAS

2458115-78-9

Created by admin on Wed Apr 02 20:35:50 GMT 2025 , Edited by admin on Wed Apr 02 20:35:50 GMT 2025

PRIMARY

INN

3472

Created by admin on Wed Apr 02 20:35:50 GMT 2025 , Edited by admin on Wed Apr 02 20:35:50 GMT 2025

PRIMARY

Related Record Type Details


					TD3XJ8R5ZS

Lirucitinib

ACTIVE MOIETY

Comments:

Janus tyrosine kinase inhibitor

Amount: